Neo Ivy Capital Management - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,077
+1167.1%
24,720
+1224.8%
0.47%
+715.5%
Q4 2022$85
-100.0%
1,866
-48.3%
0.06%
-78.3%
Q1 2022$296,000
+218.3%
3,612
+542.7%
0.27%
+184.0%
Q3 2020$93,000
-89.4%
562
-93.4%
0.09%
-71.8%
Q2 2020$881,0000.0%8,5540.0%0.33%
-33.0%
Q2 2019$881,0008,5540.50%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders